Intrinsic Value of S&P & Nasdaq Contact Us

Establishment Labs Holdings Inc. ESTA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • CR • USD

SharesGrow Score
51/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$85.00
+27.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Establishment Labs Holdings Inc. (ESTA) has a negative trailing P/E of -35.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 333.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -2.80%, forward earnings yield 0.30%. PEG 2.02.

Criteria proven by this page:

  • VALUE (90/100, Pass) — analyst target implies upside (+27.9%).
  • Forward P/E 333.9 — analysts expect a return to profitability with estimated EPS of $0.20 for FY2027.
  • PEG Ratio 2.02 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -2.80% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.30% as earnings recover.
  • Analyst consensus target $85.00 (+27.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 51/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
FUTURE
88/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
65/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ESTA

Valuation Multiples
P/E (TTM)-35.7
Forward P/E333.9
PEG Ratio2.02
Forward PEG2.02
P/B Ratio77.51
P/S Ratio8.56
EV/EBITDA-79.1
Per Share Data
EPS (TTM)$-1.72
Forward EPS (Est.)$0.20
Book Value / Share$0.79
Revenue / Share$7.13
FCF / Share$-1.94
Yields & Fair Value
Earnings Yield-2.80%
Forward Earnings Yield0.30%
Dividend Yield0.00%
Analyst Target$85.00 (+27.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -20.6 0.00 -17.31 23.11 -
2017 -10.6 -0.11 -73.96 10.69 -
2018 -22.5 0.47 6.85 7.77 -
2019 -14.9 -0.28 14.34 6.34 -
2020 -23.0 1.86 11.71 10.36 -
2021 -39.4 -7.13 31.93 12.79 -
2022 -21.3 -0.27 -196.17 9.93 -
2023 -8.4 26.00 36.03 4.01 -
2024 -15.3 6.73 24.44 7.81 -
2025 -42.3 0.99 91.68 10.23 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.20 $19.8M $-22.16M -111.9%
2017 $-1.89 $34.68M $-34.9M -100.6%
2018 $-1.22 $61.21M $-21.1M -34.5%
2019 $-1.86 $89.57M $-38.15M -42.6%
2020 $-1.63 $84.68M $-38.12M -45%
2021 $-1.72 $126.68M $-41.14M -32.5%
2022 $-3.08 $161.7M $-75.21M -46.5%
2023 $-3.07 $165.15M $-78.5M -47.5%
2024 $-3.03 $166.03M $-84.6M -51%
2025 $-1.72 $211.08M $-51.06M -24.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.01 $-1.41 – $-0.23 $264.6M $264.21M – $264.98M 4
2027 $0.20 $0.04 – $0.47 $334.17M $331.99M – $336.34M 4
2028 $1.44 $0.84 – $2.01 $415.7M $415.69M – $415.71M 6
2029 $2.34 $2.32 – $2.36 $553.3M $550.47M – $557.09M 4
2030 $3.70 $3.68 – $3.73 $669.7M $666.27M – $674.28M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message